Clinical Trial Update: A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating mapatumumab in combination with paclitaxel and carboplatin in patients with non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Mapatumumab (mapatumumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED